Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,000 shares at $934.71 ($935K) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Open-market sale of $935k REGN by EVP Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| REGN | SELL | 2024-11-05 | $845K | — | Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-09-05 | $1.2M | — | Filing → |